These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

399 related items for PubMed ID: 12476631

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Canadian Rheumatology Association Consensus on the use of anti-tumor necrosis factor-alpha directed therapies in the treatment of spondyloarthritis.
    Maksymowych WP, Inman RD, Gladman D, Thomson G, Stone M, Karsh J, Russell AS, Spondyloarthritis Research Consortium of Canada (SPARCC).
    J Rheumatol; 2003 Jun; 30(6):1356-63. PubMed ID: 12784417
    [Abstract] [Full Text] [Related]

  • 6. Etanercept and infliximab for rheumatoid arthritis.
    Drug Ther Bull; 2001 Jul; 39(7):49-52. PubMed ID: 11471515
    [Abstract] [Full Text] [Related]

  • 7. Differentiating the efficacy of tumor necrosis factor inhibitors.
    Haraoui B.
    J Rheumatol Suppl; 2005 Mar; 74():3-7. PubMed ID: 15742457
    [Abstract] [Full Text] [Related]

  • 8. Anti-tumor necrosis factor alpha blockade in the treatment of juvenile spondylarthropathy.
    Tse SM, Burgos-Vargas R, Laxer RM.
    Arthritis Rheum; 2005 Jul; 52(7):2103-8. PubMed ID: 15986366
    [Abstract] [Full Text] [Related]

  • 9. Diverse effects of infliximab and etanercept on T lymphocytes.
    Sieper J, Van Den Brande J.
    Semin Arthritis Rheum; 2005 Apr; 34(5 Suppl1):23-7. PubMed ID: 15852251
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Development of Crohn's disease following anti-tumour necrosis factor therapy (etanercept).
    Yazisiz V, Avci AB, Erbasan F, Yildirim B, Terzioğlu E.
    Colorectal Dis; 2008 Nov; 10(9):953-4. PubMed ID: 18294265
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Etanercept (Enbrel) -- an update.
    Goffe B.
    Skin Therapy Lett; 2008 Nov; 9(10):1-4, 9. PubMed ID: 15657632
    [Abstract] [Full Text] [Related]

  • 14. Tumour necrosis factor inhibitors in ankylosing spondylitis.
    Reed MR, Taylor AL.
    Intern Med J; 2008 Oct; 38(10):781-9. PubMed ID: 18422565
    [Abstract] [Full Text] [Related]

  • 15. Biological therapies in the spondyloarthritides--the current state.
    Braun J, Sieper J.
    Rheumatology (Oxford); 2004 Sep; 43(9):1072-84. PubMed ID: 15187239
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [The off-label-prescription of TNF-alpha blocking agents for spondyloarthropathies in the context of recent statement by a German federal court].
    Sieper J.
    Z Rheumatol; 2002 Dec; 61(6):688-93. PubMed ID: 12491132
    [Abstract] [Full Text] [Related]

  • 19. Anti-TNF-alpha treatment: a possible promoter in endogenous uveitis? observational report on six patients: occurrence of uveitis following etanercept treatment.
    Kakkassery V, Mergler S, Pleyer U.
    Curr Eye Res; 2010 Aug; 35(8):751-6. PubMed ID: 20673052
    [Abstract] [Full Text] [Related]

  • 20. Rapid remission of treatment-resistant ankylosing spondylitis with etanercept--a drug for refractory ankylosing spondylitis?
    Barthel HR.
    Arthritis Rheum; 2001 Aug; 45(4):404. PubMed ID: 11501730
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.